[
    [
        {
            "time": "",
            "original_text": "康泰生物：股东减持公司股份计划到期 拟减持股份",
            "features": {
                "keywords": [
                    "康泰生物",
                    "股东减持",
                    "股份计划"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物：股东减持公司股份计划到期 拟减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业中报透视CXO：板块增长强劲 边际变化持续向好",
            "features": {
                "keywords": [
                    "医药生物",
                    "CXO",
                    "板块增长",
                    "边际变化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业中报透视CXO：板块增长强劲 边际变化持续向好",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业点评：本周板块企稳 建议关注胰岛素和人工关节集采",
            "features": {
                "keywords": [
                    "医药生物",
                    "板块企稳",
                    "胰岛素",
                    "人工关节",
                    "集采"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业点评：本周板块企稳 建议关注胰岛素和人工关节集采",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华西证券：维持康泰生物(300601.SZ)“买入”评级 13价肺炎疫苗获批 有助于增厚业绩",
            "features": {
                "keywords": [
                    "华西证券",
                    "康泰生物",
                    "买入评级",
                    "13价肺炎疫苗",
                    "获批",
                    "增厚业绩"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华西证券：维持康泰生物(300601.SZ)“买入”评级 13价肺炎疫苗获批 有助于增厚业绩",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "康泰生物13价肺炎球菌疫苗获批；国内首家心磁设备厂商完成超亿元融资",
            "features": {
                "keywords": [
                    "康泰生物",
                    "13价肺炎球菌疫苗",
                    "获批",
                    "心磁设备",
                    "超亿元融资"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物13价肺炎球菌疫苗获批；国内首家心磁设备厂商完成超亿元融资",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]